FDA approves Pharming’s Joenja for children with APDS
Pharming said the FDA approved its supplemental New Drug Application for Joenja® as a first treatment for children with APDS in the U.S.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.